Documente Academic
Documente Profesional
Documente Cultură
COLLEGE OF NURSING
A case study on
Acute Decompensated
Heart Failure
Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle
doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in your
heart (coronary artery disease) or high blood pressure, gradually leave your heart too weak or
stiff to fill and pump efficiently. Citing the world health organization 2014 global status report,
the editorial noted that the risk of prematurely dying from noncommunicable diseases in the
Philippines (28 percent) is more than double in the United Kingdom (12 percent).
Pleural effusion, sometimes referred to as “water on the lungs” is the build-up of excess fluid
between the layers of the pleura outside of the lungs. The seriousness of the condition depends
on the primary cause of pleural effusion, whether breathing is affected, and whether can be
treated effectively. Causes of pleural effusion that can be effectively treated or controlled include
an infection due to virus, pneumonia or heart failure.
Five days after the patient was admitted, she was diagnosed as Acute Decompensated Heart
Failure. ADHF is a serious condition where there is a poor prognosis of the current heart disease.
In 75% of cases, acute decompensation occurs in a patient with known chronic heart failure. Of
importance, more than one-third of patients experiencing acute decompensated heart failure will
have preserved systolic function, and the outcomes of patients with preserved systolic function
seem to be like those with decreased systolic function. Factors implicated in the deterioration
included noncompliance with salt and water restriction (22%), noncardiac causes (mostly related
to pulmonary infections) (20%), medication adjustments (15%), use of an antiarrhythmic agent
within two days (15%) and arrhythmia (13%). Presenting signs and symptoms may be
progressive and include increase in body weight, shortness of breath and edema. The diagnosis
of acute decompensated heart failure may be difficult at times, and the clinical assessment and
patient profiling is essential for appropriate therapy.
Provide safe and quality nursing care by providing all the data and information about the
client.
To gain knowledge, skills and identify the needs of the patient
To organized and formulate nursing intervention of the patient
Provide Collaboration and teamwork by establishing working rapport with group mates
and the health care team present on every procedure.
To effectively provide health education through interview.
To respect the client’s rights by maintaining confidentiality and privacy of information.
C. Significance of the Study
For the Patient. To help the patient recover from the disease, and decrease the factors contributing to the
illness of the patient.
For the Family and Significant Others of the Patient. To help them understand the client’s situation and
may be able to participate in taking care of the patient.
For the Nursing Students: This study may provide additional references for making a study about
Acute Decompensated Heart Failure. It may also provide information that would help for further
researches.
For the Clinical Instructors: To appreciate the study we have made, and determine student’s
weakness, strengths, challenges, and to be able to develop a holistic case study.
For the Nursing Staffs of RPHS Annex II. To help them in managing the client’s condition, prevent the
complications for the patient, and provide extra work to understand the patient’s needs.
For the completion of our study, we have assessed patient’s functional health and gathered health
history through an interview to the patient, physical assessment and implementing nursing procedures.
We also looked over her chart to know the medications given and her latest laboratory result. The
collection of data and executing of nursing intervention took last March 26, 2019 at female ward isolation
at RPHS Annex 2. However, the nursing management were only applied until March 28, 2019 during 6
am to 2 pm shift.
E. Theoretical Framework
Wholly compensatory
Our goal is to give care, Methods of helping
Self-Care
medications and
comfort to the patient. Advocate and care for The maintenance of
the patient such as sufficient intake of
Partially collaborating with the air, food and water
compensatory team to plan for patient Provision of care
care associated with the
Nurse can bring meal
and assisting patient advocate for health and elimination process
well-being A balance between
going to bathroom
during bowel Record vital signs and activities and rest
movement. administering The preventions of
medications. hazards to human life
Supportive-educative Discharging patients and well being
from nursing care when The promotion of
system
they have regained their human functioning
Explaining patient
about her conditions at abilities to perform their
she must and not to do own self-care needs
during hospitalization
Patient’s Profile
Age 24 y/0
Birthplace Makati
Nationality Filipino
Occupation None
Religion Catholic
ROLES Patient J is currenty Patient J’s sister is the The patient’s family
RELATIONSHIP living with her sisters, one who stays with the is supportive in for
her child and her niece. her. Some family and the recovery of the
She did not mention friends came to visit patient’s health.
anything about her her during
partner and her father. hospitalization.
VALUES - BELIEF Patient J’s religion is Patient J is praying for The belief of the
Catholic. She believes her recovery. patient’s family is
that the most important helping them in
in life is to live with it hoping for the
and be happy. patient’s recovery.
PHYSICAL ASSESSMENT
Mouth & Inspection Lips pink in color; Lips are cyanotic in Blue lips occur when
Throat moist, smooth in color; missing teeth the skin on the lips
texture; ability to both on upper and takes on a bluish tint
purse lips; teeth are lower parts; ability or color. This
smooth to purse lips; generally is due to
lack of oxygen in the
blood
There was an
accumulation of
fluid in the pleural
space, in the right
there is 60ml of
fluid and in the left
there is 360ml of
fluid.
ANATOMY OF HEART
Right Side of heart – pumps deoxygenated blood into the pulmonary arteries around the lungs.
Left Side of heart – receives oxygenated blood and pumps it to the rest of the body.
Superior Vena Cava: Deoxygenated blood from the head, neck, chest, and upper extremities,
flows through this vein into the right atrium of the heart.
Inferior Vena Cava is also a large vein that leads blood from the lower extremities (trunk,
organs, pelvic region) into the right atrium of the heart.
Pulmonary valve allows blood flow from right ventricle to pulmonary artery.
Pulmonary artery sends the deoxygenated blood from the right ventricle to the lungs.
Pulmonary veins send oxygenated blood to the left atrium.
Left atrium collects oxygenated blood from the lungs and moves it to left ventricle
Left ventricle receives blood from the left atrium and sends it to the aorta.
Aortic valve opens to allow oxygen-rich blood to pass into the Aorta from the left ventricle, and
then closes to prevent blood to flow back.
Aorta: Considered the larges vessel in the body, the aorta carries oxygen-rich blood from the left
ventricle to the rest of the body.
ANATOMY OF LUNGS
The lungs are in the chest on either side of the heart in the rib cage. They are conical in shape with a
narrow-rounded apex at the top, and a broad concave base that rests on the convex surface of
the diaphragm.
Right lung - has both more lobes and segments than the left. It is divided into three lobes, an upper,
middle, and a lower, by two fissures, one oblique and one horizontal
Left lung - is divided into two lobes, an upper and a lower, by the oblique fissure, which extends
from the costal to the mediastinal surface of the lung both above and below the hilum.
Alveoli - is a hollow cavity found in the lung parenchyma and is the basic unit of ventilation.
Bronchus is a passage of airway in the respiratory system that conducts air into the lungs.
Trachea - is a cartilaginous tube that connects the pharynx and larynx to the lungs, allowing the
passage of air, and so is present in almost all air-breathing animals with lungs.
Kidneys are retroperitoneal and are located on each side of the vertebral column near the psoas
major muscles. They extend from the lower portion of the rib cage at the level of the last thoracic
(T12) vertebra to the third lumbar (L3) vertebra. Each kidney is surrounded by an outer layer of
connective tissue, called the renal capsule. Renal fascia surrounds the adipose tissue and helps
anchor the kidneys to the abdominal wall.
Hilum is a small area on the concave, medial side of the kidney that is continuous with an
adipose and connective tissue-filled cavity of the kidney, called the renal sinus.
The kidneys are organized into two major regions: an outer cortex and an inner medulla that
surrounds the renal sinus.
The medulla is composed of many cone-shaped structures called renal pyramids, whose bases
project into the cortex. These projections are called medullary rays. Between the renal pyramids
and their medullary rays, there are extensions of cortical tissue toward the medulla, called renal
columns. The renal pyramids are a collection of tubes and ducts that transport fluid throughout
the kidney and modify it into urine.
The tips of the pyramids, the renal papillae, point toward the renal sinus. In the renal sinus,
another set of tubes collects the urine for movement to the bladder. When urine leaves a renal
papilla, it empties into a small, funnel-shaped chamber surrounding the tip of the papilla called a
minor calyx.
Urine from several minor calyces are emptied into a larger, funnel-shaped chamber called a
major calyx. In each kidney, there are between 8 and 20 minor calyces converging to form about
2 or 3 major calyces. From the major calyces, urine empties into a single, enlarged, funnel-
shaped chamber called the renal pelvis. The renal pelvis is embedded in and surrounded by the
renal sinus. At the hilum, it narrows significantly, forming the small-diameter tube called the
ureter. Urine moves from the renal pelvis into the ureter for transport to the bladder.
Glomerulus - a network of capillaries twisted around each other like a ball of yarn.
Efferent arteriole transports the filtered blood away from the glomerulus
Loop of Henle - he portions of a nephron that leads from the proximal convoluted tubule to
the distal convoluted tubule.
PATHOPHYSIOLOGY
Predisposing Factor
Precipitating Factor
Alcoholic
Age: 24
Cigarette Smoker
Gender: Female
High Sodium Diet
Obesity
Tachycardia
Increased pressure in
lymph vessels Increase pressure in right atrium
and systemic venous circulation
Pleural Effusion
Decreased renal perfusion
Difficulty of breathing
Increased sodium retention
Decreased oxygen
consumption Increased osmotic pressure
Compensation of heart
muscle Increased ADH
Elimination:
8-1-18 Drug Name: Omeprazole interferes Absorption: used to reduce the - Be aware that
with gastric acid amount of acid in long-term use of
Omeprazole secretion by inhibiting absorption of your stomach. omeprazole may
the hydrogenpotassium- omeprazole takes place increase the risk of
adenosine triphosphatase in the small intestine To treat gastric carcinoma
Dosage: (H+K+-ATPase) and is usually gastroesophageal
enzyme system, or completed within 3 to reflux disease
40mg 6 hours (GERD) without
proton pump, in gastric
parietal cells. esophageal lesions,
to prevent erosive
Frequency: Distribution: esophagitis
Intravenously
Metabolism:
Omeprazole is heavily
metabolized in the
liver by the
cytochrome P450
(CYP) enzyme system.
Elimination:
3-26-19 Drug Name: Azithromycin prevents Absorption: Azithromycin is Obtain culture and
bacteria from growing indicated for the sensitivity test
Azithromycin by interfering with their Bioavailability of treatment of results, if possible,
protein synthesis. It azithromycin is 37% patients with mild before starting
binds to the 50S subunit following oral to moderate therapy.
Dosage: of the bacterial administration. infections caused
ribosome, thus by susceptible Use azithromycin
500mg tab cautiously in
inhibiting translation of strains of the
mRNA. Nucleic acid Distribution: microorganisms patients with
synthesis is not affected hepatic
Frequency: After oral dysfunction (drug
administration, is metabolized in
OD azithromycin is widely the liver) or renal
distributed in tissues dysfunction
with an apparent (effects are
Route: steady-state volume of unknown in this
distribution of 31.1 group).
Oral L/kg
Give azithromycin
capsules 1 hour
before or 2 to 3
Metabolism:
hours after food.
this drug is eliminated Give tablets or
by the liver suspension without
regard to food
Elimination:
Biliary excretion of
azithromycin,
primarily as unchanged
drug, is a major route
of elimination. Over a
1 week period,
approximately 6% of
the administered dose
is found as unchanged
drug in urine
Date Drug Name, Dosage, Pharmacodynamics Pharmacokinetics Indication Nursing
Ordered Frequency, Route Consideration
Montelukast: 8 to 11 L
Metabolism:
Levocetirizine is
poorly metabolized
and mostly excreted
via the urine
Montelukast:
Metabolized in the
liver
Elimination:
Levocitirizine:
Excreted in urine.
Montelukast:
8-1-18 Drug Name: Butamirate citrate, the Absorption: Symptomatic Assess cough type
sole active ingredients treatment of and frequency
Butamitrate Citrate of Sinecod, is a cough Based on available data, it cough of various Monitor the
suppressant which is can be assumed that the origins. adverse reactions
neither chemically, nor ester butamirate is well and
Dosage: pharmacologically rapidly absorbed and that it Assess patients
related to opium is hydrolyzed into phenyl- vital signs
50mg 2-butyric acid and
alkaloids
diethylaminoethoxyethanol.
Frequency:
Distribution:
TID
Butamirate has a high
volume of distribution
Route: ranging between 81 and
112 L
Oral
Metabolism:
Elimination:
Excretion of the three
metabolites takes place
primarily via the kidneys;
following conjugation in
the liver, the acid
metabolites undergo large-
scale binding to glucuronic
acid. Urinary 2-
phenylbutyric acid
conjugate levels are much
higher than in plasma.
Not available
Frequency:
q8 Metabolism:
Small amount
Route: metabolized in the
liver
Intravenous
Elimination:
8-2-18 Drug Name: Semisynthetic third- Absorption: For treatment of -Determine history
generation the infections of hypersensitivity
Ceftriaxone cephalosporin antibiotic. Immediate after IV to cephalosporins
Preferentially binds to infusion and penicillins
one or more of the
Dosage: penicillin-binding
proteins located on the Distribution:
2g
walls of susceptible
Widely distributed in
organisms. This inhibits
tissues and fluids
third and final stage of
Frequency: bacterial cell wall
synthesis, killing the
Q24 Metabolism:
bacterium.
Not metabolized
Route:
Intravenous Elimination:
33-65% excreted
unchanged in urine
Date Drug Name, Dosage, Pharmacodynamics Pharmacokinetics Indication Nursing
Ordered Frequency, Route Consideration
Inhalation
Elimination:
7-30-18 Drug Name: Anti-ischemic agent Absorption: Indicated for use - Taken with food
which improves in angina pectoris
Trimetazidine myocardial glucose Well absorbed
utilization through -May cause
inhibition of long-chain dizziness and
Dosage: 3-ketoacyl CoA thiolase Distribution: drowsiness
activity which results in
35mg Not available
reduction in fatty acid
oxidation and a
stimulation of glucose
Frequency: oxidation. Metabolism:
Route:
Elimination:
Oral
Urine
Date Drug Name, Dosage, Pharmacodynamics Pharmacokinetics Indication Nursing
Ordered Frequency, Route Consideration
7-30-18 Drug Name: Febuxostat, a xanthine Absorption: For the treatment Instruct patients to
oxidase inhibitor, of hyperuricemia contact health care
Febuxostat achieves its therapeutic The absorption of provider if they
effect by decreasing radiolabeled febuxostat experience chest
serum uric acid. following oral dose pain, rash,
Dosage: administration was shortness of breath
estimated to be at least
40mg 49%
Advise patients
that product may
Frequency: Distribution: be taken without
OD The mean apparent regard to meals
steady state volume of
distribution (Vss/F) of
Route: febuxostat was
approximately 50 L
Oral (CV ~40%)
Metabolism:
Febuxostat is
extensively metabolized
by both conjugation via
uridine diphosphate
glucuronosyltransferase
(UGT) enzymes
including UGT1A1,
UGT1A3, UGT1A9,
and UGT2B7 and
oxidation via
cytochrome P450
(CYP) enzymes
including CYP1A2,
2C8 and 2C9 and non-
P450 enzymes.
Elimination:
Febuxostat is
eliminated primarily
through both hepatic
and renal pathways.
Date Drug Name, Dosage, Pharmacodynamics Pharmacokinetics Indication Nursing
Ordered Frequency, Route Consideration
7-30-18 Drug Name: Aldactone is a specific Absorption: For the monitor I and O
pharmacologic management of ratios and daily
Aldactone antagonist of Absorbed in the GI edema and sodium weight, BP
aldosterone, acting tract retention when the
primarily through patient is only Take with meals or
Dosage: competitive binding of partially milk; avoid
receptors at the Distribution: responsive to, or is excessive ingestion
50mg of food high in
aldosterone-dependent intolerant of, other
Not available potassium or use of
sodium-potassium therapeutic
exchange site in the measures. salt substitutes
Frequency: distal convoluted renal
tubule. Aldactone causes Metabolism:
BID
increased amounts of
Rapidly and
sodium and water to be
extensively
excreted, while
Route: metabolized. The
potassium is retained.
metabolic pathway of
Oral spironolactone is
complex and can be
divided into two main
routes: those in which
the sulfur moiety is
retained and those in
which the sulfur
moiety is removed by
dethioacetylation.
Elimination:
7-30-18 Drug Name: Lanoxin, a cardiac Absorption: For the treatment Drug-induced
glycoside similar to and management arrhythmias may
Lanoxin digitoxin, is used to treat Absorption of digoxin of congestive increase the
congestive heart failure from the elixir cardiac severity of heart
and supraventricular pediatric formulation insufficiency, failure and
Dosage: arrhythmias due to has been demonstrated arrhythmias and hypotension.
reentry mechanisms, and to be 70% to 85% heart failure.
0.25mg complete ( 60% to 80% Before giving
to control ventricular
rate in the treatment of for tablets). loading dose
chronic atrial ,obtain baseline
Frequency: fibrillation. data heart rate and
Distribution: rhythm, blood
OD pressure
Not available
Before fore giving
drug, take apical-
Route:
radial pulse for
Metabolism:
Oral 1minute. Record
Metabolized in the and notify
liver prescriber of
significant changes
Elimination:
7-30-18 Drug Name: For inotropic support in Absorption: For inotropic Tell patient to
the short- term treatment support in the report adverse
Dobutamine of patients with cardiac Not Available short- term reactions promptly,
decompensation due to treatment of especially labored
depressed contractility patients with breathing and
Dosage: resulting either from Distribution: cardiac drug-induced
organic heart disease decompensation headache
18cc/hour Not available
due to depressed
contractility
resulting either Instruct patient to
Metabolism: from organic heart report discomfort
disease at I.V. insertion
Route: Not Available
site
Intravenously
Elimination:
HEMATOLOGY
March 25,2019
March 25,2019
Parameter Result
Transparency Hazy
WBC 15 – 20
RBC 5
Bacteria Many
Chem Form 1
March 26,2019
Uric acid 623 143 - 339 uric acid levels are associated
with increased risk of
ischemic heart disease and
blood pressure
IMMUNO HEMATOLOGY
PROTHROMBIN TIME
MARCH 27,2019
HEMATOLOGY
MARCH 28,2019
Low number of
monocytes can be
Monocytes 02 4 – 8%
caused by the
infection in the lungs
ASSESSMENT NURSING ANALYSIS PLANNING INTERVENTION RATIONALE EVALUATION
DIAGNOSIS
Subjective Ineffective Inspiration ST: After 15 Nsg. Nsg. Action GOAL MET
Data: breathing and/or expiration that Order:
minutes of Independent: ST: After 15
pattern R/T does not provide
“Nahihirapan pleural adequate ventilation. nursing To minutes of
ako huminga” assist Place patient A sitting nursing
effusion as intervention, the with proper position
as verbalized evidenced by client intervention,
by the patient client will in body permits the client was
the alignment maximum
perform deep finding able to perform
ultrasound for lung
and breathing method deep breathing
for maximum excursion and exercises.
Objective decreased exercises breathing chest
Data: oxygen pattern. expansion.
saturation as LT: After 1 hour
RR: 30
evidenced by of nursing
O2 Sat: 92% RR of 30, O2
intervention, the This method LT: After 1
saturation of
Nasal Flaring client will be relaxes hour of nursing
92% Encourage muscles and intervention,
able to remain exercising
Dyspnea, increases the the client was
respiratory rate deep patient’s able to remain
Crackles breathing
within oxygen level. respiratory rate
established of 21 breathes
per minute.
limits.
Dependent: To provide
Provide oxygen
oxygen
therapy, as demands
ordered
Assist
with ADLs To decrease activity
(activities of of patient that could
daily worsen the
living) regularly condition.
as indicated by
the physician.
Subjective Acute Pain Unpleasant ST Goal: Nsg. Order Nsg. Action GOAL MET
Data: R/T sensory and
myocardial emotional After 15-30 Independent: In acute pain, bed ST: After 15
infarction as experience mins. of rest may necessary mins, Patient
N.I., Patient To assist client to Suggest the to limit pain. T’s pain scale
“Masakit evidenced by arising from explore methods patient to lie Sitting position
verbalization actual or T’s pain decreases
yung dibdib scale of 8 for in bed in promotes from 8 to 4
ko” as of pain and a potential alleviation/control sitting
pain scale of tissue will oxygenation via
verbalized by improved to of pain position or maximum chest
the patient 8/10. damage or High
described in 4 expansion and
Fowler’s facilitates the
terms of Position for relaxing of tension
such comfort and of the abdominal
damage. promote muscles, allowing
Objective total bed improved
Data: rest. breathing.
Pain scale of
8/10 in.
Restlessness
BP: 100/60
T: 36.6
Isosorbide
P: 83
mononitrate dilates
RR: 33 Dependent: (widens) blood
vessels, making it
Administer easier for blood to
Isosorbide flow through them
To Promote Mononitrate
Wellness and easier for
according to the heart to pump.
doctor’s
order.
Discharge Instructions for Acute Decompensated Heart Failure
You have been diagnosed with Acute Decompensated Heart Failure commonly known as a heart
attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the
heart muscle. The most common symptom is chest pain or discomfort which may travel into the
shoulder, arm, back, neck, or jaw.
Home Care
Take your medicines exactly as directed. Don’t skip doses. Talk with your healthcare
provider if your medicines aren't working for you. Together you can come up with
another treatment plan.
Remember that recovery after a heart attack takes time. Plan to rest for at least 4 to 8
weeks while you recover. Then return to normal activity when your doctor says it’s OK.
Call emergency hotline right away if you have chest pain or pain that goes to your
shoulder, neck, or back. Don't drive yourself to the hospital.
Ask your family members to learn CPR. This is an important skill that can save lives
when it's needed.
Learn to take your own blood pressure and pulse. Keep a record of your results. Ask your
doctor when you should seek emergency medical attention. He or she will tell you which
blood pressure reading is dangerous.
Diet and Lifestyle
DO NOT drink any alcohol for at least 2 weeks. Ask your provider when you may start.
Limit how much you drink. Women should have only 1 drink a day, and men should have
no more than 2 a day. Try to drink alcohol only when you are eating.
If you smoke, stop. Ask your provider for help quitting if you need it. DO NOT let
anybody smoke in your home, since second-hand smoke can harm you. Try to stay away
from things that are stressful for you. If you are feeling stressed all the time, or if you are
feeling very sad, talk with your provider. They can refer you to a counselor.
Consume a diet high in vegetables, fruits, whole grains, low-fat dairy products,
poultry, fish, legumes, non-tropical oils, and nuts, and reduce intake of sweets, sugar-
added beverages and red meats. Avoid salty foods.
Home Medication